Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GYNTAP: Intraoperative TAP Block for Gynecologic Surgery
NCT02506855Phase 3Withdrawn
- Sponsor
- University of Mississippi Medical Center
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in postoperative pain comparing Ropivacaine with Placebo (2 arms). Primary endpoint: Milligrams of Diludid Consumption During First 48 hours Following Surgery. Planned start Jun 2015; status: withdrawn.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02506855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02506855.